Myriad Genetics | MYGN - Net Income


Myriad Genetics reported $-27.4M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Agilent USD 434M 98M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Bruker USD -62.4M 70M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Illumina USD 150M 85M Sep/2025
J&J USD 5.12B 36M Dec/2025
Mettler Toledo International USD 217.49M 15.14M Sep/2025
Myriad Genetics USD -27.4M 303.1M Sep/2025
Quest Diagnostics USD 245M 37M Sep/2025
Quidel USD -733M 477.6M Sep/2025
Repligen USD 14.91M 44K Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Standard Biotools USD -34.69M 1.23M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Veracyte USD 19.14M 20.12M Sep/2025
Waters USD 148.92M 1.81M Sep/2025